Paschalis Evangelidis: A New Way to Treat iTTP by Targeting the Autoimmune Process
Paschalis Evangelidis, Former Teaching Assistant at Aristotle University of Thessaloniki (AUTH) shared a post on LinkedInย about a recent article he and Eleni Gavriilakiย co-authored, adding:
”Excited to share our insightful commentary on immune-mediated thrombotic thrombocytopenic purpura (iTTP):
This piece highlights a promising shift in how we think about iTTP – not just managing acute episodes, but targeting the underlying autoimmune process.
A novel approach using red blood cells to deliver ADAMTS13 antigens in an ‘immune-silent’ way could help induce immune tolerance and reduce relapses.
While still early, this strategy opens the door to more precise, long-term solutions beyond conventional immunosuppression.
A small but meaningful step toward solving another piece of the TTP puzzle.”
Title: Solving another piece of the thrombotic thrombocytopenic purpura puzzle?
Authors: Paschalis Evangelidis, Eleni Gavriilaki
Stay updated on all scientific advances withย Hemostasis Today.
-
Sep 4, 2026, 03:18Mukesh Kumar Maurya: Beyond โaPL Thrombosisโ – A Modern Approach to APS
-
Sep 4, 2026, 02:44Ahmed Kotb: Emergency Management of Critical Bleeding in ITP
-
Sep 4, 2026, 02:30Mario Jimenez: KDIGO 2026 – A More Proactive Approach to IV Iron in Hemodialysis
-
Sep 4, 2026, 02:18Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF
-
Sep 3, 2026, 20:33Jennifer Weinstein: Happy to Share Our New Work on the Patient Experience in VWD at the NBDF Conference
-
Sep 3, 2026, 20:31Guillaume Courbon: New Publication on Erythroid-Produced FGF23 and Its Role in Anemia
-
Sep 3, 2026, 20:30Phuong Khanh Morrow: FDA Approval Marks an Important Step Forward for the PV Community
-
Sep 3, 2026, 20:29Sarah Robins: Happy to Share This Portrait Film I Voiced for the NNHHF
-
Sep 3, 2026, 20:27Mireille Muller: Europe Needs More Plasma Donors